Tower Research Capital LLC (Trc) Pep Gen Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Pep Gen Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,839 shares of PEPG stock, worth $37,156. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,839
Previous 9,570
18.09%
Holding current value
$37,156
Previous $10,000
260.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PEPG
# of Institutions
78Shares Held
57.1MCall Options Held
1.14MPut Options Held
103K-
Ra Capital Management, L.P. Boston, MA20.1MShares$95.1 Million1.59% of portfolio
-
Viking Global Investors LP3.48MShares$16.5 Million0.05% of portfolio
-
Commodore Capital LP New York, NY2.36MShares$11.2 Million0.7% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.33MShares$11 Million1.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.21MShares$10.5 Million0.0% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $112M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...